Pharmaceutical Firm Enrolls First US Patient in Phase 2b/3 Ifenprodil COVID-19 Trial
Source: Streetwise Reports  (8/17/20)
Algernon Pharmaceuticals reported it has enrolled the first U.S. patient in its multinational Phase 2b/3 human study of Ifenprodil for use in treatment of SARS-CoV-2. More >

Canadian Biotech Advances Antibodies, Diagnostics Programs in Q2/20
Source: Streetwise Reports  (8/14/20)
One highlight is ProMIS Neurosciences' development of a SARS CoV-2 antibody test. More >

Telemedicine Firm Continues Expansion by Acquiring Majority Interest in Ontario Medical Clinic
Source: Streetwise Reports  (8/14/20)
The clinic will be integrated into the CloudMD EMR platform. More >

Mesoblast Shares Rocket Higher as FDA Committee Votes in Favor of Remestemcel-L for Pediatric SR-aGVHD Patients
Source: Streetwise Reports  (8/14/20)
Shares of Mesoblast Ltd. traded 50% higher after the company reported that the U.S. FDA's Oncologic Drugs Advisory Committee voted nine to one in favor of remestemcel-L (RYONCILâ„¢) for efficacy in children with steroid-refractory acute graft versus host disease. More >

Life Sciences Firm Signs MOU for Phase 3 COVID-19 Study
Source: Streetwise Reports  (8/14/20)
Revive Therapeutics reported it signed a MOU with Attwill Medical Solutions Sterilflow to be a clinical packaging and distribution resource for its Phase 3 clinical trial of Bucillamine in COVID-19. More >

Biotech Develops Oral Film Strips for Psychedelic Medicine Delivery
Source: Streetwise Reports  (8/12/20)
This development is a technical milestone for Revive Therapeutics and its drug delivery technology. More >

Pennant Group Shares Fly 40% Higher on Q2 Earnings and Raised FY Adjusted EPS Guidance
Source: Streetwise Reports  (8/12/20)
Shares of The Pennant Group reached a new 52-week high after the company reported a 12.1% increase in Q2/20 revenue and raised FY/20 adjusted EPS guidance by 34.2%. More >

Life Sciences Company Registers First Non-Antibiotic Livestock Feed Additive Sale in Brazil
Source: Streetwise Reports  (8/12/20)
Avivagen Inc. reported it achieved its first sale of OxC-betaâ„¢ Livestock in Brazil, the world's third largest livestock feed market. More >

Eyenovia Shares Look 38% Higher on Development Deal with Arctic Vision in Asia
Source: Streetwise Reports  (8/11/20)
Shares of Eyenovia Inc. set a new 52-week high after the firm reported it entered into an exclusive collaboration and license agreement with Arctic Vision to develop and market MicroPine and MicroLine in China and South Korea. More >

Seres Therapeutics Shares Go Parabolic on Positive Topline Data from Phase 3 C.Diff Trial
Source: Streetwise Reports  (8/10/20)
Seres Therapeutics shares traded 350% higher setting a new 52-week high after the firm reported positive topline results from its SER-109 Phase 3 ECOSPOR III study in recurrent C. difficile infection. More >

Is Summit's Ridinilazole a Threat to Acurx's Ibezapolstat in the C.difficile Space?
Source: Dr. KSS, MD, PhD, for Streetwise Reports  (8/10/20)
Dr. KSS, the founder and editor-in-chief of BioPub.co, compares the two drugs as potential treatments for C. difficile. More >

$18.5 Billion Merger Could Mean Big Gains for These Five Tiny Telemedicine Stocks
Source: Matt Badiali for Streetwise Reports  (8/10/20)
Independent financial analyst Matt Badiali examines five small companies poised to profit as digital health becomes mainstream during the coronavirus pandemic. More >

Pharmaceutical Firm Doses First Patient in Phase 2 IPF and Chronic Cough Trial
Source: Streetwise Reports  (8/8/20)
Algernon Pharmaceuticals reported that the first patient has been dosed in the Phase 2 human study of Ifenprodil for treatment of idiopathic pulmonary fibrosis and chronic cough. More >

Biopharma Preparing to Initiate Phase 3 COVID-19 Trial
Source: Streetwise Reports  (8/7/20)
Revive Therapeutics is now "finalizing agreements and aligning resources to initiate the Phase 3 clinical trial in September." More >

Denali Shares Rise 37% on Advancement of DNL151 into Late Stage Parkinson's Trials
Source: Streetwise Reports  (8/6/20)
Shares of Denali Therapeutics reached a new 52-week high after the company reported plans to advance DNL151 in two separate late stage Parkinson's disease clinical studies with its partner Biogen. More >

US Immunology Firm Lands Government Contract, Raises Cash
Source: Streetwise Reports  (8/5/20)
These two CytoSorbents events are discussed in a Dawson James report. More >

Tech Firm Explains Key Feature of its Contact Tracing Solution
Source: Streetwise Reports  (8/5/20)
Loop Insights' technology lacks the adoption challenges that app-based solutions face. More >

Fulgent Genetics' Shares Reach New 52-Week High After Posting 105% Increase in Q2 Revenue
Source: Streetwise Reports  (8/5/20)
Shares of Fulgent Genetics traded 22% higher after the company reported it posted a record $17.1 million in Q2/20 revenue and completed a record 180,513 billable tests in the quarter. More >

Mobile Health Tech Firm Joins with US Healthcare Group to Bring Care Platform to 50,000 Patients
Source: Streetwise Reports  (8/4/20)
Reliq Health Technologies reported it has entered into a new contract with Diversified Healthcare Partners to provide its iUGO Care platform to more than 50,000 patients in three U.S. states. More >

Biopharma Gets FDA Approval for Phase 3 COVID-19 Trial
Source: Streetwise Reports  (8/4/20)
Revive Therapeutics' trial will test Bucillamine in patients with mild to moderate COVID-19. More >

Ten Good Reasons to Invest Now Pre-Market in Acurx Pharmaceuticals
Source: Dr. KSS, MD, PhD, for Streetwise Reports  (8/3/20)
Dr. KSS, the founder and editor-in-chief of BioPub.co, provides his investment thesis for a company that is promulgating the first new class of antibiotics in 30 years. More >

Coverage Initiated on 'Emerging Colossus in Diagnostics and Life Science'
Source: Streetwise Reports  (7/29/20)
Meridian Bioscience's business segments, revenue and growth as well as COVID-19's positive impact on them are reviewed in an H.C. Wainwright & Co. report. More >

Digital Health Firm Signs Deal to Acquire Vancouver Medical Clinic Serving 60,000 Patients
Source: Streetwise Reports  (7/29/20)
CloudMD reported it entered into a definitive agreement to acquire South Surrey Medical Clinic in Metro Vancouver in a combination stock and cash deal valued at CA$700,000. More >

Kodak Shares Triple in a Flash on $765 Million Loan from DFC for New Pharmaceutical Unit
Source: Streetwise Reports  (7/28/20)
Eastman Kodak shares traded more than 200% higher after the company reported it is forming a new business unit to produce essential pharmaceutical components funded by the U.S. International Development Finance Corporation. More >

TCR2 Therapeutics Reports Positive Results in Mesothelin-Expressing Solid Tumor Study
Source: Streetwise Reports  (7/27/20)
Shares of TCR2 Therapeutics traded 30% higher after the firm released encouraging results from the Phase 1 portion of its clinical study of TC-210 in treating advanced mesothelin-expressing solid tumors.

More >